Lumenis Launches UltraPulse® DUO at the ELS Congress and Invites ENT Physicians to Join LINK, A New Revolutionary Platform f...
June 08 2016 - 4:00AM
Lumenis Ltd., the world’s largest energy-based medical device
company for surgical, aesthetic and ophthalmic applications,
launches the UltraPulse DUO CO2 advanced laser platform alongside
LINK, a new communication channel for ENT medical professionals, at
the 11th congress of the European Laryngological Society (ELS),
taking place in Genoa, Italy, from June 8-11, 2016.
A photo accompanying this announcement is available
at: http://www.globenewswire.com/NewsRoom/AttachmentNg/f9368928-ff52-4bc1-8cd7-291f1e13d7e9
For years, UltraPulse has been synonymous
with precision in transoral laser microsurgery. The new
UltraPulse DUO features the ultra-precise Digital AcuBlade scanning
micromanipulator capabilities and high CO2 laser fiber energy
within the same platform. By seamlessly alternating between the two
energy deliveries, surgeons can access challenging anatomy beyond
their line-of-sight and treat hard-to-reach areas with great
delicacy and precision.
“Providing precise, individualized patient care can be
challenging for ENT surgeons because of the broad spectrum of
surgical situations that can arise during the procedure,” commented
Marc Remacle, M.D., Ph.D., Centre Hospitalier de Luxembourg. “With
the combined modality of the CO2 laser and the easy shift between
free beam and fiber deliveries I can delicately address any
clinical challenge while preserving healthy tissue, which is very
important for the patient’s recovery and comfort.”
This unique combination of two laser energy deliveries is
available only with the Lumenis’ DUO platforms, which also includes
the AcuPulse™ DUO, which is the first integrated CO2 laser system.
Both the UltraPulse DUO and the AcuPulse DUO systems are
accompanied by a wide range of surgical accessories, along
with cost effective fibers that feature renewable tips,
an aiming beam and high energy transmission.The versatile Lumenis
DUO product line is designed for smart tissue management and for
optimal treatment of hard-to-reach delicate anatomy and is the
result of the strong collaboration with the ENT community.
This strong collaboration also yielded LINK, an advanced
communication channel introduced at the ELS conference. Lumenis
invites ELS attendees to join LINK at the Lumenis booth to be the
first to take part in a revolutionary platform that will change the
way experts communicate. Created to encourage the sharing of
knowledge between industry experts, the multi-platform provides
users with an opportunity to learn from CO2 laser specialists
around the world, grants access to resources of procedures and
serves as an open communication channel for discussion.
“Lumenis’ dedication to excellence is expressed not only through
our continued development of advanced products and innovative
technologies, but also in our strong partnerships with leading head
and neck, ENT professionals and primary educational institutions to
create advanced enlightening activities through innovative
communication channels,” said Tzipi Ozer-Armon, CEO of Lumenis.
During the ELS conference, Lumenis will offer various
educational activities where surgeons have the opportunity to
experience smart tissue management technology first hand:
- Instructional course on CO2 laser techniques and new approaches
for LT Stenosis and HPV, to be given by Dr.’s Isabela Vilaseca and
Guri Sandhu Friday, June 10 at 11:00 – 12:00 in room
Libeccio
- Meet the expert session where attendees will be able to meet
Prof. Paul Castellanos, M.D., Associate Professor of Surgery at the
University of Alabama at Birmingham, who will share his experience
with UltraPulse DUO Friday, June 10 at 12:30 – 13:00 and
15:00 – 15:30 in room Sala Marine
- Lumenis’ hands-on-lab featuring Leica Microsystems and Pentax
will be open for visitors from Thursday, June 9 through Friday,
June 10, allowing practice exercises in our fully equipped lab
About Lumenis Lumenis is a global leader in the
field of minimally-invasive clinical solutions for the Surgical,
Ophthalmology and Aesthetic markets, and is a world-renowned expert
in developing and commercializing innovative energy-based
technologies, including Laser, Intense Pulsed Light (IPL),
Radio-Frequency (RF) and Ultrasound. For nearly 50 years, Lumenis'
ground-breaking products have redefined medical treatments and have
set numerous technological and clinical gold-standards. Lumenis has
successfully created solutions for previously untreatable
conditions, as well as designed advanced technologies that have
revolutionized existing treatment methods. For more information
visit: www.lumenis.com
For further information:
Glenn Silver
Lazar Partners Ltd.
(646) 871-8495
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From May 2024 to Jun 2024
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From Jun 2023 to Jun 2024